159 related articles for article (PubMed ID: 37141704)
1. Insurance-Based Disparities in Guideline-Concordant Thyroid Cancer Care in the Era of De-escalation.
Ginzberg SP; Soegaard Ballester JM; Wirtalla CJ; Pryma DA; Mandel SJ; Kelz RR; Wachtel H
J Surg Res; 2023 Sep; 289():211-219. PubMed ID: 37141704
[TBL] [Abstract][Full Text] [Related]
2. Racial and Ethnic Disparities in Appropriate Thyroid Cancer Treatment, Before and After the Release of the 2015 American Thyroid Association Guidelines.
Ginzberg SP; Soegaard Ballester JM; Wirtalla CJ; Morales KH; Pryma DA; Mandel SJ; Kelz RR; Wachtel H
Ann Surg Oncol; 2023 May; 30(5):2928-2937. PubMed ID: 36749501
[TBL] [Abstract][Full Text] [Related]
3. Insurance Status Is Associated with Extent of Treatment for Patients with Papillary Thyroid Carcinoma.
Ullmann TM; Gray KD; Limberg J; Stefanova D; Moore MD; Buicko J; Finnerty B; Zarnegar R; Fahey TJ; Beninato T
Thyroid; 2019 Dec; 29(12):1784-1791. PubMed ID: 31502525
[No Abstract] [Full Text] [Related]
4. Insurance type is associated with appropriate use of surgical and adjuvant care for differentiated thyroid carcinoma.
Thiesmeyer JW; Limberg J; Ullmann TM; Greenberg JA; Egan CE; Moore M; Finnerty BM; Laird AM; Zarnegar R; Fahey TJ; Beninato T
Surgery; 2022 Jan; 171(1):140-146. PubMed ID: 34600741
[TBL] [Abstract][Full Text] [Related]
5. The effect of guideline-concordant care in mitigating insurance status disparities in cervical cancer.
Wu J; Huang Y; Tergas AI; Melamed A; Khoury-Collado F; Hou JY; St Clair CM; Ananth CV; Hershman DL; Wright JD
Gynecol Oncol; 2020 Nov; 159(2):309-316. PubMed ID: 32800656
[TBL] [Abstract][Full Text] [Related]
6. Postoperative Surveillance in Older Adults With T1N0M0 Low-risk Papillary Thyroid Cancer.
Pradhan MC; Kazaure HS; Wang F; Zambeli-Ljepovic A; Perkins JM; Stang MT; Scheri RP
J Surg Res; 2021 Aug; 264():37-44. PubMed ID: 33765509
[TBL] [Abstract][Full Text] [Related]
7. Medicaid insurance is associated with treatment disparities for proximal humerus fractures in a national database analysis.
Truong NM; Zhuang T; Leversedge C; Ma CB; Kamal RN; Shapiro LM
J Shoulder Elbow Surg; 2023 Jul; 32(7):e366-e378. PubMed ID: 36581135
[TBL] [Abstract][Full Text] [Related]
8. Effect of insurance and racial disparities on outcomes in traumatic brain injury.
Schiraldi M; Patil CG; Mukherjee D; Ugiliweneza B; Nuño M; Lad SP; Boakye M
J Neurol Surg A Cent Eur Neurosurg; 2015 May; 76(3):224-32. PubMed ID: 25798799
[TBL] [Abstract][Full Text] [Related]
9. Association of insurance status and ethnicity with cancer stage at diagnosis for 12 cancer sites: a retrospective analysis.
Halpern MT; Ward EM; Pavluck AL; Schrag NM; Bian J; Chen AY
Lancet Oncol; 2008 Mar; 9(3):222-31. PubMed ID: 18282806
[TBL] [Abstract][Full Text] [Related]
10. Black and Hispanic women are less likely than white women to receive guideline-concordant endometrial cancer treatment.
Kaspers M; Llamocca E; Quick A; Dholakia J; Salani R; Felix AS
Am J Obstet Gynecol; 2020 Sep; 223(3):398.e1-398.e18. PubMed ID: 32142825
[TBL] [Abstract][Full Text] [Related]
11. Prostate cancer outcomes for men aged younger than 65 years with Medicaid versus private insurance.
Mahal AR; Mahal BA; Nguyen PL; Yu JB
Cancer; 2018 Feb; 124(4):752-759. PubMed ID: 29084350
[TBL] [Abstract][Full Text] [Related]
12. Impact of insurance status on receipt of definitive surgical therapy and posttreatment outcomes in early stage lung cancer.
Stokes SM; Wakeam E; Swords DS; Stringham JR; Varghese TK
Surgery; 2018 Dec; 164(6):1287-1293. PubMed ID: 30170821
[TBL] [Abstract][Full Text] [Related]
13. Access denied: The relationship between patient insurance status and access to high-volume hospitals.
Nabi J; Tully KH; Cole AP; Marchese M; Cone EB; Melnitchouk N; Kibel AS; Trinh QD
Cancer; 2021 Feb; 127(4):577-585. PubMed ID: 33084023
[TBL] [Abstract][Full Text] [Related]
14. Association of race and health insurance in treatment disparities of colon cancer: A retrospective analysis utilizing a national population database in the United States.
Hao S; Snyder RA; Irish W; Parikh AA
PLoS Med; 2021 Oct; 18(10):e1003842. PubMed ID: 34695123
[TBL] [Abstract][Full Text] [Related]
15. INITIAL ADOPTION OF RECOMBINANT HUMAN THYROID-STIMULATING HORMONE FOLLOWING THYROIDECTOMY IN THE MEDICARE THYROID CANCER PATIENT POPULATION.
Dinan MA; Li Y; Reed SD; Sosa JA
Endocr Pract; 2019 Jan; 25(1):31-42. PubMed ID: 30383499
[TBL] [Abstract][Full Text] [Related]
16. Healthcare Access Dimensions and Guideline-Concordant Ovarian Cancer Treatment: SEER-Medicare Analysis of the ORCHiD Study.
Montes de Oca MK; Wilson LE; Previs RA; Gupta A; Joshi A; Huang B; Pisu M; Liang M; Ward KC; Schymura MJ; Berchuck A; Akinyemiju TF
J Natl Compr Canc Netw; 2022 Nov; 20(11):1255-1266.e11. PubMed ID: 36351338
[TBL] [Abstract][Full Text] [Related]
17. Is There an Association Between Insurance Status and Survival and Treatment of Primary Bone and Extremity Soft-tissue Sarcomas? A SEER Database Study.
Smartt AA; Jang ES; Tyler WK
Clin Orthop Relat Res; 2020 Mar; 478(3):527-536. PubMed ID: 31390340
[TBL] [Abstract][Full Text] [Related]
18. Disparity in the use of adjuvant radioactive iodine ablation among high-risk papillary thyroid cancer patients.
Moten AS; Zhao H; Intenzo CM; Willis AI
Eur J Surg Oncol; 2019 Nov; 45(11):2090-2095. PubMed ID: 31253543
[TBL] [Abstract][Full Text] [Related]
19. Relationship between insurance status and interhospital transfers among cancer patients in the United States.
Rubens M; Ramamoorthy V; Saxena A; Appunni S; Sundil S; Veledar E; McGranaghan P; Tonse R; Fitz SJT; Chuong MD; Odia Y; Kotecha R; Mehta MP; Kotecha R
BMC Cancer; 2022 Jan; 22(1):121. PubMed ID: 35093015
[TBL] [Abstract][Full Text] [Related]
20. Association of Diabetes and Other Clinical and Sociodemographic Factors With Guideline-concordant Breast Cancer Treatment for Breast Cancer.
Gold HT; Shao H; Oratz R; Yu O; Hammer M; Richardson S; Boudreau D
Am J Clin Oncol; 2020 Feb; 43(2):101-106. PubMed ID: 31850918
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
